TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 24 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $647,930 | – | 1,000,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 41,167 | $26,722 | 2.14% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,500,000 | $8,093,188 | 1.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 26,500,000 | $17,217,315 | 0.72% |
| BRAIDWELL LP | 28,350,000 | $18,393,480 | 0.58% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $16,144,712 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 45,400,000 | $29,373,729 | 0.33% |
| Lion Point Capital, LP | 1,000,000 | $647,930 | 0.29% |
| Segantii Capital Management Ltd | 7,500,000 | $4,873,085 | 0.17% |
| READYSTATE ASSET MANAGEMENT LP | 3,000,000 | $1,946,400 | 0.10% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 23,393,000 | $15,177,378 | 0.07% |